BIIB Related Hot Upgrades
-
Goldman Sachs Upgrades Amgen (AMGN) to Conviction Buy
-
BofA/Merrill Lynch Upgrades Biogen (BIIB) to Buy
-
Goldman Sachs Upgrades Biogen (BIIB) to Buy, Sees 16% Upside
-
Goldman Sachs Adds Gilead Sciences (GILD) to the Conviction Buy List on Acquisition Strategy
-
UBS Upgrades Biogen (BIIB) to Buy
-
Deutsche Bank Upgrades Biogen (BIIB) to Buy
Back to BIIB Stock Lookup
